- Lupin Strikes $90m Settlement With Astellas On Myrbetriq
- Organon And Henlius Settle US Perjeta Litigation
- Fresenius Kabi And Phlow Partner On End-To-End US Epinephrine Supply Chain
- CVS Health beats the Street on both earnings, revenue in Q4
- CVS Health beats the Street on both earnings, revenue in Q4
- Care navigation startup Garner Health scores $118M series D at $1.35B valuation
- Care navigation startup Garner Health scores $118M series D at $1.35B valuation
- CMS plans to roll back limits on nonstandard ACA plan options
- CMS plans to roll back limits on nonstandard ACA plan options
- Bio-Thera Partners With Avalon Pharma For Keytruda Biosimilar In Middle East
- Lupin Strikes $90m Settlement With Astellas On Myrbetriq
- Organon And Henlius Settle US Perjeta Litigation
- Fresenius Kabi And Phlow Partner On End-To-End US Epinephrine Supply Chain
- CVS Health beats the Street on both earnings, revenue in Q4
- Care navigation startup Garner Health scores $118M series D at $1.35B valuation
- CMS plans to roll back limits on nonstandard ACA plan options
- Bio-Thera Partners With Avalon Pharma For Keytruda Biosimilar In Middle East
- Mental health startups chosen for One Mind Accelerator
- Breckenridge Expands Injectables Portfolio Through Medichem Collaboration
- Doximity CEO bullish on winning the AI market in 2026 as it rolls out physician-led AI review
Tag: DIFS
Page 1 / 2
Next
Page 1 / 2
Next
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.











